Influence of the A and B subunits of cholera toxin (CT) and Escherichia coli toxin (IT) on TNF-α release from macrophages

被引:8
作者
Domingos, M. O. [1 ]
Andrade, R. G. [1 ]
Barbaro, K. C. [2 ]
Borges, M. M. [1 ]
Lewis, D. J. [3 ]
New, R. R. C. [4 ]
机构
[1] Butantan Inst, Bacteriol Lab, BR-05503900 Sao Paulo, Brazil
[2] Butantan Inst, Immunopathol Lab, BR-05503900 Sao Paulo, Brazil
[3] St Georges Med Sch, Dept Infect Dis, London SW17 0RE, England
[4] London Biosci, Proxima Concepts Ltd, London NW1 0NH, England
关键词
TNF-alpha; Cholera toxin; Heat-labile toxin; LPS; Macrophages; HEAT-LABILE ENTEROTOXIN; MUCOSAL ADJUVANT; HUMAN MONOCYTES; CYCLIC-AMP; MODULATION; VACCINE; LIPOPOLYSACCHARIDE; PRETREATMENT; CELLS;
D O I
10.1016/j.toxicon.2008.12.017
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study an in vitro model was developed with the aim of investigating the modulatory effect of cholera toxin (CT) and its counterpart the heat labile toxin of Escherichia coli (IT) on TNF-alpha release induced by murine macrophages and primary human monocytes. Previous studies have demonstrated that the enzymatic activity of CT and IT molecules can inhibit TNF-alpha release by macrophages. The results obtained in this study showed that CT and IT are both, in a dose dependent manner, able either to induce or inhibit TNF-alpha release by murine macrophages and primary human monocytes. The results also showed that recombinant B subunits of CT and IT in the absence of their A subunit induce high levels of TNF-alpha release by macrophages and, in addition, increase the level of TNF-alpha release induced by LPS. The ability of both B subunits (CTB and LTB) in inducing TNF-alpha release by macrophages is not related to the level of LPS contamination, since direct measurements of LPS made in the samples employed in this study showed only traces of LPS (3.4 x 10(-8) EU/ml) which is in our system does not induce TNF-alpha release by macrophages. In contrast to the results obtained with the B subunits, incubation of cells with the A subunit of CT (CTA) inhibit TNF-alpha release induced by native CT, native IT, recombinant LTB and LPS. This inhibitory effect must be related to the activity of the A subunit since viability tests performed in terms of metabolic rate demonstrated that high concentrations of CIA are not toxic to the cells. The data presented herein demonstrate that the A subunits of CT and IT have an inhibitory effect on TNF-alpha release in macrophages, whereas their B subunits have a stimulatory effect on TNF-alpha. The results also suggest that the dose dependent bi-modal effect of native CT and native LT on TNF-alpha release by macrophages is a result of the combined effect of their individual A and B subunits. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:570 / 577
页数:8
相关论文
共 22 条
  • [1] Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit ctokine production through a cyclic AMP-dependent pathway
    Bagley, KC
    Abdelwahab, SF
    Tuskan, RG
    Fouts, TR
    Lewis, GK
    [J]. INFECTION AND IMMUNITY, 2002, 70 (10) : 5533 - 5539
  • [2] BLOCK MI, 1992, ARCH SURG-CHICAGO, V127, P1330
  • [3] Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide
    Burkart, V
    Kim, YE
    Hartmann, B
    Ghiea, I
    Syldath, U
    Kauer, M
    Fingberg, W
    Hanifi-Moghaddani, P
    Müller, S
    Kolb, H
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (04) : 1730 - 1737
  • [4] de Haan L, 2000, J NAT TOXINS, V9, P281
  • [5] Domingos MO, 2008, OPEN DRUG DELIV J, V2, P52
  • [6] LT(K63/R72), a new mutant of Escherichia coli heat-labile enterotoxin, exhibits characteristics more similar to LT(K63) than LT(R72)
    Feng, Q
    Yang, J
    Luo, P
    Zhang, WJ
    Zou, QM
    [J]. ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2005, 37 (02) : 126 - 132
  • [7] B subunit of E-coli enterotoxin as adjuvant and carrier in oral and skin vaccination
    Fingerut, E.
    Gutter, B.
    Goldway, M.
    Eliahoo, D.
    Pitcovski, J.
    [J]. VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2006, 112 (3-4) : 253 - 263
  • [8] FISHMAN PH, 1993, ADV LIPID RES, V25, P165
  • [9] Glück U, 1999, J VIROL, V73, P7780
  • [10] KATAKAMI Y, 1988, IMMUNOLOGY, V64, P719